Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
68.04
-3.14 (-4.41%)
Oct 30, 2026, 4:00 PM EDT - Market closed
Inspire Medical Systems Stock Forecast
Stock Price Forecast
According to 18 analysts polled by S&P Global, Inspire Medical Systems stock has a consensus rating of "Hold" and an average price target of $68. The average 1-year stock price forecast is 0.06% lower than the current stock price, while the lowest is $40 (-41.21%) and the highest is $97 (+42.56%).
Price Target: $68 (-0.06%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Inspire Medical Systems stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 11 | 12 | 12 | 11 | 11 | 11 |
| Sell | 1 | 1 | 1 | 1 | 1 | 2 |
| Strong Sell | 0 | 0 | 1 | 1 | 1 | 1 |
| Total | 15 | 16 | 17 | 17 | 17 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Financial | Truist Financial | Hold Maintains $62 → $78 | Hold | Maintains | $62 → $78 | +14.64% | Oct 14, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Reiterates $65 → $75 | Buy | Reiterates | $65 → $75 | +10.23% | Oct 13, 2026 |
Unknown Analyst Leerink Partners No rating | Leerink Partners | Hold Maintains $59 → $67 | Hold | Maintains | $59 → $67 | -1.53% | Oct 12, 2026 |
| Barclays | Barclays | Sell Initiates $65 | Sell | Initiates | $65 | -4.47% | Oct 6, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $60 | Hold | Maintains | $60 | -11.82% | Oct 2, 2026 |
Financial Forecast
Revenue This Year
853.86M
from 911.98M
Decreased by -6.37%
Revenue Next Year
887.18M
from 853.86M
Increased by 3.90%
EPS This Year
1.25
from 2.42
Decreased by -48.36%
EPS Next Year
1.54
from 1.25
Increased by 22.95%
EPS and Forward PE are based on non-GAAP adjusted numbers.